These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9310272)

  • 1. Effects of prostaglandin E1 infusion on limb hemodynamics and vasodilatory response in patients with arteriosclerosis obliterans.
    Makita S; Nakamura M; Ohhira A; Itoh S; Hiramori K
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):441-8. PubMed ID: 9310272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of prostaglandin E-1 in patients with intermittent claudication.
    Milio G; Coppola G; Novo S
    Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):71-6. PubMed ID: 16787192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine improves post-ischemic vasodilation in coronary heart disease patients taking vasodilating drugs.
    Iannuzzi A; Iannuzzo G; Sapio C; Pauciullo P; Iorio D; Spampinato N; Mancini M; Rubba P
    J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):121-7. PubMed ID: 11509918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costs.
    Belcaro G; Laurora G; Nicolaides AN; Agus G; Cesarone MR; DeSanctis MT; Incandela L; Ricci A; Cazaubon M; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Iacobitti P; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Bucci M; Ferrari PG; Corsi M; Pomante P; Mezzanotte L; Geroulakos G
    Angiology; 1998 Nov; 49(11):885-94; discussion 895. PubMed ID: 9822044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T; Eckstein H; Weiss C; Diehm C
    Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
    Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
    Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential effects of prostaglandin E1 and nitroglycerin on regional cerebral oxygenation in anesthetized patients.
    Kadoi Y; Saito S; Morita T; Imai T; Kawahara H; Fujita N; Goto F
    Anesth Analg; 1997 Nov; 85(5):1054-9. PubMed ID: 9356099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
    Ishihara T; Yamashita Y; Takasaki N; Yamamoto S; Hayashi E; Tahara K; Takenaga M; Yamakawa N; Ishihara T; Kasahara T; Mizushima T
    J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial.
    Belcaro G; Nicolaides AN; Agus G; Cesarone MR; Geroulakos G; Pellegrini L; De Sanctis MT; Incandela L; Ricci A; Mondani P; De Angelis R; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Dugall M; Bucci M; Martines G; Ferrari PG; Corsi M; Di Francescantonio D
    Angiology; 2000 Aug; 51(8 Pt 2):S15-26. PubMed ID: 10959507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
    Okuro M; Morimoto S; Takahashi T; Okaishi K; Nakahashi T; Murai H; Iwai K; Kanda T; Matsumoto M
    Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.
    Makino H; Aoki M; Hashiya N; Yamasaki K; Hiraoka K; Shimizu H; Azuma J; Kurinami H; Ogihara T; Morishita R
    Hypertens Res; 2004 Feb; 27(2):85-91. PubMed ID: 15005271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model.
    Nakai K; Takenobu Y; Eguchi K; Takimizu H; Honjo K; Akimaru S; Maegawa H; Marsala M; Katsube N
    Anesth Analg; 2002 Jun; 94(6):1537-41, table of contents. PubMed ID: 12032022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.